HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip G Penketh Selected Research

hydrazine (hydrazine dihydrochloride)

11/20114-nitrobenzyloxycarbonyl derivatives of O(6)-benzylguanine as hypoxia-activated prodrug inhibitors of O(6)-alkylguanine-DNA alkyltransferase (AGT), which produces resistance to agents targeting the O-6 position of DNA guanine.
10/20111,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical properties.
6/2010Reductive activation of the prodrug 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119) selectively occurs in oxygen-deficient cells and overcomes O(6)-alkylguanine-DNA alkyltransferase mediated KS119 tumor cell resistance.
10/2008Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating species.
11/2005Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine.
1/2005The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip G Penketh Research Topics

Disease

24Neoplasms (Cancer)
01/2021 - 01/2005
8Hypoxia (Hypoxemia)
02/2013 - 06/2005
6Carcinoma (Carcinomatosis)
01/2016 - 11/2008
4Leukemia
01/2016 - 01/2005
2Ovarian Epithelial Carcinoma
03/2016 - 01/2016
2Fanconi Anemia (Fanconi's Anemia)
01/2016 - 03/2012
2Glioma (Gliomas)
05/2011 - 11/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2008 - 01/2005

Drug/Important Bio-Agent (IBA)

14ProdrugsIBA
01/2021 - 01/2005
12laromustine (VNP40101M)IBA
01/2018 - 01/2005
10O(6)-Methylguanine-DNA MethyltransferaseIBA
05/2015 - 12/2008
8DNA (Deoxyribonucleic Acid)IBA
01/2016 - 04/2006
6Oxygen (Dioxygen)IBA
08/2012 - 11/2008
6hydrazine (hydrazine dihydrochloride)IBA
11/2011 - 01/2005
5Proteins (Proteins, Gene)FDA Link
05/2015 - 11/2011
5Carmustine (FIVB)FDA Link
08/2014 - 05/2005
5GuanineIBA
06/2013 - 12/2008
4Temozolomide (Temodar)FDA LinkGeneric
06/2013 - 12/2008
41,2- bis(methylsulfonyl)- 1- - (2- chloroethyl)- 2- ((1- (4- nitrophenyl)ethoxy)carbonyl)hydrazineIBA
10/2011 - 06/2005
3Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 02/2013
3O(6)-benzylguanineIBA
02/2013 - 11/2011
3Alkyl and Aryl TransferasesIBA
02/2013 - 04/2006
3EnzymesIBA
11/2011 - 11/2008
2Carboplatin (JM8)FDA LinkGeneric
03/2016 - 01/2016
2Cisplatin (Platino)FDA LinkGeneric
03/2016 - 01/2016
2PlatinumIBA
03/2016 - 01/2016
23-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
03/2016 - 01/2016
2Alkylating AgentsIBA
06/2013 - 11/2010
2Oxidoreductases (Dehydrogenase)IBA
11/2011 - 05/2011
2Cytotoxins (Cytolysins)IBA
10/2011 - 06/2005
1Etoposide (VP 16)FDA LinkGeneric
03/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2016
1olaparibIBA
03/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2016
1Paclitaxel (Taxol)FDA LinkGeneric
01/2016
1IsoenzymesIBA
08/2014
1MethyltransferasesIBA
06/2013
17-nitro-4-(phenylthio)benzofurazanIBA
10/2012
1Superoxides (Superoxide)IBA
10/2012
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2012
1DNA alkyltransferaseIBA
08/2012
1TransferasesIBA
03/2012
11,2- bis(methylsulfonyl)- 1- (2- chloroethyl)hydrazineIBA
06/2005
1Sulfhydryl Compounds (Thiols)IBA
06/2005
1AnnexinsIBA
01/2005
1methyl isocyanateIBA
01/2005

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2016
1Radiotherapy
03/2012
1Therapeutics
03/2007